Heterodimerization of the alpha and beta isoforms of the human thromboxane receptor enhances isoprostane signaling.
Isoprostanes are free radical catalyzed products of arachidonic acid that are elevated in pro-oxidant disease states. Two isoprostanes, 8-isoprostaglandin F(2alpha) (iPF(2alpha)III) and 8-isoprostaglandin E2 (iPE2III), act at the receptor for thromboxane A2 (the TP) to mediate pro-atherogenic effects in vivo. We confirmed dimerization of the human TP isoforms, TPalpha and TPbeta, and determined the impact on isoprostane signaling. No overt changes in ligand binding at the TP were observed as a result of TPalpha/TPbeta coexpression. The response to iPF(2alpha)III or iPE2III was enhanced in HEK293 cells stably coexpressing TPalpha and TPbeta, as measured by inositol phosphate generation or intracellular calcium mobilization, relative to cells expressing TPalpha or TPbeta individually. In contrast, the response to traditional thromboxane analogs was unaltered. Augmented isoprostane signaling was similarly observed in HEK 293 cell transiently transfected with TPalpha and TPbeta. These results indicate that TPalpha/TPbeta dimerization enhances isoprostane-mediated signal transduction.
Wilson
Stephen J
SJ
Institute of Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA.
McGinley
Kevin
K
Huang
Albert J
AJ
Smyth
Emer M
EM
D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D019281:Dimerization; D006801:Humans; D028421:Isoprostanes / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism*; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D017482:Receptors, Thromboxane / Q000737:chemistry* / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*
D028421:Isoprostanes; D020033:Protein Isoforms; D017482:Receptors, Thromboxane; D011994:Recombinant Proteins; D002118:Calcium